Insurers’ policies for chronic pain medications are missing important opportunities to steer patients to safer and more effective treatments than opioids, according to a study by researchers at Johns Hopkins Bloomberg School of Public Health.
The study found that many insurers failed to apply evidence-based “utilization management” rules to discourage opioid overuse, and many rules were applied as often to nonopioids as opioids.
